This inventor holds 1 USPTO granted patent. Top assignee: Behringwerke Aktiengesellschaft. Active years: 1995.
Company Filing History:
Years Active: 1995
Title: Bernard Knapp: Innovator in Malaria Vaccine Development
Introduction
Bernard Knapp is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of vaccine development, particularly in combating malaria. His work has the potential to save countless lives by providing effective immunization against this deadly disease.
Latest Patents
Bernard Knapp holds a patent for a Plasmodium falciparum vaccine comprising a recombinant histidine-rich protein. This innovative vaccine is designed to protect against malaria caused by the Plasmodium falciparum parasite. The patent details the preparation and use of this recombinant protein, which has shown promise in protecting aotus monkeys from infection.
Career Highlights
Throughout his career, Bernard Knapp has been associated with Behringwerke Aktiengesellschaft, a company known for its advancements in biopharmaceuticals. His research has focused on isolating genes that code for protective proteins against malaria, showcasing his dedication to public health and scientific advancement.
Collaborations
Bernard has collaborated with esteemed colleagues such as Burkhard Enders and Hans Kupper. These partnerships have enhanced the research and development of malaria vaccines, contributing to the collective effort in fighting infectious diseases.
Conclusion
Bernard Knapp's innovative work in malaria vaccine development exemplifies the impact of dedicated research in the field of medicine. His contributions are vital in the ongoing battle against malaria, highlighting the importance of scientific innovation in improving global health.